Unlike most adipokines, plasma levels of adiponectin are markedly decreased in obesity and its related metabolic complications, and are inversely associated with glucolipid profiles and insulin sensitivity (Achari and Jain, 2017; Hui et al, 2012). Here, ADIPOQ is linked to obesity disorder.